Cargando…

P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine

Detalles Bibliográficos
Autores principales:	Latka, M, Grey, G, Fielding, K, Bekker, L, Mlisana, K, Nchabeleng, M, DeBruin, G, Allen, M, Kublin, J, Churchyard, G
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767678/ http://dx.doi.org/10.1186/1742-4690-6-S3-P187

Ejemplares similares

Pregnancy Incidence and Correlates during the HVTN 503 Phambili HIV Vaccine Trial Conducted among South African Women
por: Latka, Mary H., et al.
Publicado: (2012)

HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials
por: Volk, JE, et al.
Publicado: (2012)

P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
por: Gray, GE, et al.
Publicado: (2009)

P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
por: Mark, D, et al.
Publicado: (2009)

P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial
por: de Bruyn, G, et al.
Publicado: (2009)

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses
por: Hopkins, Kathryn L., et al.
Publicado: (2014)

P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa
por: Allen, MA, et al.
Publicado: (2009)

Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men
por: Moodie, Zoe, et al.
Publicado: (2015)

Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial
por: Mpofu, Rephaim, et al.
Publicado: (2021)

The aftermath of the Merck's HIV vaccine trial
por: Iaccino, Enrico, et al.
Publicado: (2008)

Uptake of Genital Mucosal Sampling in HVTN 097, a Phase 1b HIV Vaccine Trial in South Africa
por: Lazarus, Erica Maxine, et al.
Publicado: (2014)

Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
por: Koblin, B, et al.
Publicado: (2012)

A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
por: Churchyard, Gavin J., et al.
Publicado: (2011)

Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial
por: Pantaleo, Giuseppe, et al.
Publicado: (2019)

Discovery medicine – the HVTN's iterative approach to developing an HIV-1 broadly neutralizing vaccine
por: Martin, Troy M., et al.
Publicado: (2023)

2896. Oral PrEP Uptake among HVTN 704/HPTN 085 Participants: Implications for the Future of Biomedical HIV Prevention Trials
por: Cantos, Valeria D, et al.
Publicado: (2023)

The Merck manual
por: Porter, Robert S.
Publicado: (2011)

Merck's Annual
Publicado: (1907)

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
por: Laher, Fatima, et al.
Publicado: (2020)

Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)
por: Peiperl, Laurence, et al.
Publicado: (2010)

The Merck veterinary manual /
Publicado: (2016)

Merck's 1907 Index
Publicado: (1908)

Merck's Annual Report
Publicado: (1910)

Carbon Tetrachloride, Merck
por: Merck, E.
Publicado: (1930)

The Merck index : an encyclopedia of chemicals, drugs, and biologicals /
Publicado: (2006)

The Merck index : an encyclopedia of chemicals, drugs, and biologicals /
Publicado: (1989)

The Merck index : an encyclopedia of chemicals, drugs, and biologicals /
Publicado: (2001)

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120
por: deCamp, Allan C., et al.
Publicado: (2017)

Synthetica Merck : Reagenzien für die organische Synthese /
Publicado: (1969)

P06-08. Building an African HIV preventive trial network
por: Price, MA, et al.
Publicado: (2009)

The Merck manual of medical information /
Publicado: (1999)

The merck manual of diagnosis and theraphy
Publicado: (1977)

The Merck Manual of Diagnosis and Therapy
por: Lipsey, Lewis R.
Publicado: (1988)

The Merck Index of Chemicals and Drugs
Publicado: (1952)

Merck's Actions Surrounding Vioxx
por: Heinley, Michael
Publicado: (2006)

The Merck manual of diagnosis and therapy /
Publicado: (1966)

Manual Merck de veterinaria
Publicado: (2007)

The Merck manual of diagnosis and therapy
Publicado: (1966)

Merck's Annual Report, 1912
Publicado: (1914)

El Manual Merck : de diagnóstico y terapéutica
por: Berkow, Robert, 1929-
Publicado: (1978)

Cannot write session to /tmp/vufind_sessions/sess_dqn76ugk3n7b5tv2k0codsecvf